25 XP   0   0   10

Compass Therapeutics Inc.
Buy, Hold or Sell?

Let's analyse Compass Therapeutics Inc. together

PenkeI guess you are interested in Compass Therapeutics Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Compass Therapeutics Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Compass Therapeutics Inc.

I send you an email if I find something interesting about Compass Therapeutics Inc..

Quick analysis of Compass Therapeutics Inc. (30 sec.)










What can you expect buying and holding a share of Compass Therapeutics Inc.? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.08
Expected worth in 1 year
$0.84
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-0.24
Return On Investment
-15.8%

For what price can you sell your share?

Current Price per Share
$1.52
Expected price per share
$1.15 - $2.5726
How sure are you?
50%

1. Valuation of Compass Therapeutics Inc. (5 min.)




Live pricePrice per Share (EOD)

$1.52

Intrinsic Value Per Share

$-3.69 - $-4.34

Total Value Per Share

$-2.61 - $-3.26

2. Growth of Compass Therapeutics Inc. (5 min.)




Is Compass Therapeutics Inc. growing?

Current yearPrevious yearGrowGrow %
How rich?$148.5m$139.7m$23.2m14.3%

How much money is Compass Therapeutics Inc. making?

Current yearPrevious yearGrowGrow %
Making money-$10.1m-$9.1m-$956.2k-9.4%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Compass Therapeutics Inc. (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#306 / 1009

Most Revenue
#981 / 1009

Most Profit
#563 / 1009

Most Efficient
#423 / 1009

What can you expect buying and holding a share of Compass Therapeutics Inc.? (5 min.)

Welcome investor! Compass Therapeutics Inc.'s management wants to use your money to grow the business. In return you get a share of Compass Therapeutics Inc..

What can you expect buying and holding a share of Compass Therapeutics Inc.?

First you should know what it really means to hold a share of Compass Therapeutics Inc.. And how you can make/lose money.

Speculation

The Price per Share of Compass Therapeutics Inc. is $1.52. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Compass Therapeutics Inc..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Compass Therapeutics Inc., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.08. Based on the TTM, the Book Value Change Per Share is $-0.06 per quarter. Based on the YOY, the Book Value Change Per Share is $0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Compass Therapeutics Inc..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.10-6.4%-0.08-5.1%-0.07-4.7%-0.08-5.5%-0.08-5.2%
Usd Book Value Change Per Share-0.08-5.5%-0.06-4.0%0.085.0%0.063.7%0.053.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.08-5.5%-0.06-4.0%0.085.0%0.063.7%0.053.6%
Usd Price Per Share1.56-2.50-2.83-1.72-1.63-
Price to Earnings Ratio-4.00--8.71--9.70--5.50--5.23-
Price-to-Total Gains Ratio-18.65--46.21--25.10--47.07--47.07-
Price to Book Ratio1.45-2.08-2.70-3.39-3.22-
Price-to-Total Gains Ratio-18.65--46.21--25.10--47.07--47.07-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.52
Number of shares657
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.060.06
Usd Total Gains Per Share-0.060.06
Gains per Quarter (657 shares)-39.5137.34
Gains per Year (657 shares)-158.06149.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-158-1680149139
20-316-3260299288
30-474-4840448437
40-632-6420597586
50-790-8000747735
60-948-9580896884
70-1106-1116010461033
80-1264-1274011951182
90-1422-1432013441331
100-1581-1590014941480

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.019.00.00.0%0.020.00.00.0%0.020.00.00.0%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%4.015.00.021.1%4.016.00.020.0%4.016.00.020.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.019.00.0%0.00.020.00.0%0.00.020.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%4.015.00.021.1%4.016.00.020.0%4.016.00.020.0%

Fundamentals of Compass Therapeutics Inc.

About Compass Therapeutics Inc.

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. The company's lead product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 a ligand of Notch-1, and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells. It also develops CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-11 02:24:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Compass Therapeutics Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Compass Therapeutics Inc. earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Compass Therapeutics Inc. to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Compass Therapeutics Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY--288.3%+288.3%
5Y--449.1%+449.1%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient Compass Therapeutics Inc. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Compass Therapeutics Inc. to the Biotechnology industry mean.
  • -8.6% Return on Assets means that Compass Therapeutics Inc. generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Compass Therapeutics Inc.:

  • The MRQ is -8.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.6%TTM-6.0%-2.6%
TTM-6.0%YOY-6.2%+0.2%
TTM-6.0%5Y-69,572.7%+69,566.7%
5Y-69,572.7%10Y-66,099.9%-3,472.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.6%-13.3%+4.7%
TTM-6.0%-12.8%+6.8%
YOY-6.2%-11.7%+5.5%
5Y-69,572.7%-13.9%-69,558.8%
10Y-66,099.9%-15.7%-66,084.2%
1.1.3. Return on Equity

Shows how efficient Compass Therapeutics Inc. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Compass Therapeutics Inc. to the Biotechnology industry mean.
  • -9.0% Return on Equity means Compass Therapeutics Inc. generated $-0.09 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Compass Therapeutics Inc.:

  • The MRQ is -9.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.0%TTM-6.3%-2.7%
TTM-6.3%YOY-6.8%+0.4%
TTM-6.3%5Y-18.6%+12.2%
5Y-18.6%10Y-17.6%-0.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.0%-16.9%+7.9%
TTM-6.3%-16.1%+9.8%
YOY-6.8%-15.1%+8.3%
5Y-18.6%-19.3%+0.7%
10Y-17.6%-20.2%+2.6%

1.2. Operating Efficiency of Compass Therapeutics Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Compass Therapeutics Inc. is operating .

  • Measures how much profit Compass Therapeutics Inc. makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Compass Therapeutics Inc. to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Compass Therapeutics Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY--298.2%+298.2%
5Y--492.1%+492.1%
10Y--632.4%+632.4%
1.2.2. Operating Ratio

Measures how efficient Compass Therapeutics Inc. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Compass Therapeutics Inc.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY-3.890-3.890
5Y-5.739-5.739
10Y-7.876-7.876

1.3. Liquidity of Compass Therapeutics Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Compass Therapeutics Inc. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 19.73 means the company has $19.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Compass Therapeutics Inc.:

  • The MRQ is 19.726. The company is very able to pay all its short-term debts. +2
  • The TTM is 18.116. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ19.726TTM18.116+1.610
TTM18.116YOY13.058+5.058
TTM18.1165Y8.933+9.183
5Y8.93310Y8.493+0.439
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ19.7263.890+15.836
TTM18.1164.173+13.943
YOY13.0585.344+7.714
5Y8.9336.126+2.807
10Y8.4936.448+2.045
1.3.2. Quick Ratio

Measures if Compass Therapeutics Inc. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Compass Therapeutics Inc. to the Biotechnology industry mean.
  • A Quick Ratio of 16.44 means the company can pay off $16.44 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Compass Therapeutics Inc.:

  • The MRQ is 16.438. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 27.689. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ16.438TTM27.689-11.251
TTM27.689YOY20.223+7.466
TTM27.6895Y12.350+15.339
5Y12.35010Y11.739+0.610
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ16.4383.514+12.924
TTM27.6893.998+23.691
YOY20.2235.380+14.843
5Y12.3506.105+6.245
10Y11.7396.404+5.335

1.4. Solvency of Compass Therapeutics Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Compass Therapeutics Inc. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Compass Therapeutics Inc. to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.05 means that Compass Therapeutics Inc. assets are financed with 5.3% credit (debt) and the remaining percentage (100% - 5.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Compass Therapeutics Inc.:

  • The MRQ is 0.053. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.060. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.053TTM0.060-0.007
TTM0.060YOY0.090-0.030
TTM0.0605Y8.341-8.281
5Y8.34110Y8.271+0.070
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0530.339-0.286
TTM0.0600.336-0.276
YOY0.0900.271-0.181
5Y8.3410.366+7.975
10Y8.2710.389+7.882
1.4.2. Debt to Equity Ratio

Measures if Compass Therapeutics Inc. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Compass Therapeutics Inc. to the Biotechnology industry mean.
  • A Debt to Equity ratio of 5.6% means that company has $0.06 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Compass Therapeutics Inc.:

  • The MRQ is 0.056. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.064. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.056TTM0.064-0.008
TTM0.064YOY0.099-0.035
TTM0.0645Y0.156-0.092
5Y0.15610Y0.149+0.008
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0560.388-0.332
TTM0.0640.402-0.338
YOY0.0990.335-0.236
5Y0.1560.426-0.270
10Y0.1490.461-0.312

2. Market Valuation of Compass Therapeutics Inc.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Compass Therapeutics Inc. generates.

  • Above 15 is considered overpriced but always compare Compass Therapeutics Inc. to the Biotechnology industry mean.
  • A PE ratio of -4.00 means the investor is paying $-4.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Compass Therapeutics Inc.:

  • The EOD is -3.897. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.000. Based on the earnings, the company is expensive. -2
  • The TTM is -8.713. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.897MRQ-4.000+0.103
MRQ-4.000TTM-8.713+4.713
TTM-8.713YOY-9.696+0.983
TTM-8.7135Y-5.505-3.208
5Y-5.50510Y-5.230-0.275
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.897-2.264-1.633
MRQ-4.000-2.629-1.371
TTM-8.713-2.680-6.033
YOY-9.696-4.145-5.551
5Y-5.505-6.257+0.752
10Y-5.230-6.254+1.024
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Compass Therapeutics Inc.:

  • The EOD is -4.229. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.340. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.941. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.229MRQ-4.340+0.111
MRQ-4.340TTM-8.941+4.601
TTM-8.941YOY-12.097+3.155
TTM-8.9415Y-8.477-0.464
5Y-8.47710Y-8.053-0.424
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.229-2.973-1.256
MRQ-4.340-3.333-1.007
TTM-8.941-3.553-5.388
YOY-12.097-5.605-6.492
5Y-8.477-8.376-0.101
10Y-8.053-8.865+0.812
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Compass Therapeutics Inc. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.45 means the investor is paying $1.45 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Compass Therapeutics Inc.:

  • The EOD is 1.408. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.445. Based on the equity, the company is underpriced. +1
  • The TTM is 2.076. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.408MRQ1.445-0.037
MRQ1.445TTM2.076-0.631
TTM2.076YOY2.696-0.620
TTM2.0765Y3.394-1.317
5Y3.39410Y3.224+0.170
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.4081.896-0.488
MRQ1.4452.115-0.670
TTM2.0762.093-0.017
YOY2.6962.884-0.188
5Y3.3943.542-0.148
10Y3.2243.916-0.692
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Compass Therapeutics Inc..

3.1. Institutions holding Compass Therapeutics Inc.

Institutions are holding 62.84% of the shares of Compass Therapeutics Inc..

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Orbimed Advisors, LLC16.25340.69672236285000
2023-12-31Adage Capital Partners Gp LLC7.18080.03199880000350000054.8589
2023-12-31HHG PLC4.75850.00616547231-113407-1.7026
2023-12-31BlackRock Inc4.52240.000362223092485744.1611
2023-12-31Blackstone Inc4.49860.0436618955100
2023-09-30BRAIDWELL LP4.32760.3707595427300
2023-12-31Rock Springs Capital Management LP4.00740.2118551378800
2023-12-31FMR Inc3.3080.00064551506-1587-0.0349
2023-12-31Vanguard Group Inc2.96620.00014081189-26330-0.641
2023-12-31Vivo Capital, LLC2.58450.4542355602300
2023-12-31Blue Owl Capital Holdings LP2.05661.0552282971228297120
2023-09-30CHI Advisors LLC2.05662.2094282971200
2023-12-31Geode Capital Management, LLC1.44780.00031992028997075.269
2023-12-31State Street Corporation1.25470.00011726304-29809-1.6974
2023-12-31Avidity Partners Management LP1.16260.0909159960000
2023-12-31Baker Bros Advisors LP1.13210.0277155763000
2023-12-31Ally Bridge Group (NY) LLC0.60660.7758834630-80000-8.7467
2023-12-31Northern Trust Corp0.55220.0002759733-65381-7.9239
2023-12-31Monashee Investment Management LLC0.36340.1377500000-726142-59.2217
2023-12-31Millennium Management LLC0.35910.000349409218746961.1399
Total 65.39916.113689982161+5822806+6.5%

3.2. Funds holding Compass Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Biotech Growth Ord2.59571.3213357142800
2024-02-29Vanguard Total Stock Mkt Idx Inv1.59020.0003218797200
2024-03-28iShares Russell 2000 ETF1.580.0066217386010470.0482
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.97580.0023134262700
2024-01-31Fidelity Small Cap Index0.66010.0048908249259602.9423
2024-03-28iShares Russell 2000 Value ETF0.56610.0123778839-494-0.0634
2024-02-29Fidelity Extended Market Index0.40140.0026552276-2676-0.4822
2024-02-29Janus Henderson Hrzn Biotec E2 USD0.3960.3702544814-165063-23.2523
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.3880.002353390000
2024-02-29Fidelity Select Biotechnology0.31140.015542843600
2024-02-29Vanguard Russell 2000 ETF0.23790.0061327367259888.623
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.22240.006230600000
2023-12-31NT R2000 Index Fund - NL0.18240.0054251013-14869-5.5923
2023-09-30BlackRock Extended Mkt Composite0.1690.003323246615970.6917
2023-12-31NT R2000 Value Index Fund - NL0.16430.0093226094-15337-6.3525
2024-02-29Schwab Small Cap Index0.15430.006421224590004.4282
2024-03-31BlackRock Extended Equity Market K0.14570.0027200528720.0359
2024-03-28iShares Micro-Cap ETF0.14450.042819881600
2023-12-31NT R2000 Index Fund - DC - NL - 20.14370.0054197676-12517-5.955
2024-02-29iShares Russell 2000 Small-Cap Idx Instl0.12560.006717286200
Total 11.15451.832515347468-147292-1.0%

3.3. Insider Transactions

Insiders are holding 13.437% of the shares of Compass Therapeutics Inc..

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-03-10Thomas J SchuetzBUY100003.37
2023-02-27Thomas J SchuetzBUY200003.98
2023-02-15Thomas J SchuetzBUY200003.86
2023-01-31Thomas J SchuetzBUY200004.05
2023-01-24Thomas J SchuetzBUY200004.19
2022-11-25Vered Bisker-leibSELL24.36
2022-11-22Vered Bisker-leibSELL149294.19
2022-11-08Orbimed Advisors LlcBUY4020003.21
2022-09-28Thomas J SchuetzBUY100002.32
2022-09-26Thomas J SchuetzBUY150002.27
2022-08-10Thomas J SchuetzBUY150002.64
2022-08-01Thomas J SchuetzBUY150002.58
2022-06-21Thomas J SchuetzBUY200002.8
2022-06-16Thomas J SchuetzBUY200002.34
2022-06-13Thomas J SchuetzBUY300002.29
2022-06-06Thomas J SchuetzBUY300002.83
2022-06-01Thomas J SchuetzBUY200003.03
2022-05-26Thomas J SchuetzBUY200003.04
2022-05-23Thomas J SchuetzBUY183552.72
2022-05-13Carl L GordonBUY307222.49

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Compass Therapeutics Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.084-0.060-28%0.076-211%0.057-247%0.054-255%
Book Value Per Share--1.0801.185-9%1.016+6%0.558+93%0.530+104%
Current Ratio--19.72618.116+9%13.058+51%8.933+121%8.493+132%
Debt To Asset Ratio--0.0530.060-12%0.090-41%8.341-99%8.271-99%
Debt To Equity Ratio--0.0560.064-12%0.099-43%0.156-64%0.149-62%
Dividend Per Share----0%-0%-0%-0%
Eps---0.098-0.077-21%-0.071-27%-0.083-15%-0.079-19%
Free Cash Flow Per Share---0.090-0.074-18%-0.063-30%-0.052-42%-0.049-45%
Free Cash Flow To Equity Per Share---0.091-0.069-25%0.075-221%0.042-316%0.040-328%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---4.342--------
Intrinsic Value_10Y_min---3.689--------
Intrinsic Value_1Y_max---0.263--------
Intrinsic Value_1Y_min---0.258--------
Intrinsic Value_3Y_max---0.922--------
Intrinsic Value_3Y_min---0.877--------
Intrinsic Value_5Y_max---1.738--------
Intrinsic Value_5Y_min---1.602--------
Market Cap209135267.840-3%214638827.520343284535.040-37%389720819.840-45%236363405.204-9%224545234.944-4%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio1.408-3%1.4452.076-30%2.696-46%3.394-57%3.224-55%
Pe Ratio-3.897+3%-4.000-8.713+118%-9.696+142%-5.505+38%-5.230+31%
Price Per Share1.520-3%1.5602.495-37%2.833-45%1.718-9%1.632-4%
Price To Free Cash Flow Ratio-4.229+3%-4.340-8.941+106%-12.097+179%-8.477+95%-8.053+86%
Price To Total Gains Ratio-18.175+3%-18.653-46.208+148%-25.100+35%-47.069+152%-47.069+152%
Quick Ratio--16.43827.689-41%20.223-19%12.350+33%11.739+40%
Return On Assets---0.086-0.060-30%-0.062-28%-695.727+813483%-660.999+772872%
Return On Equity---0.090-0.063-30%-0.068-25%-0.186+106%-0.176+95%
Total Gains Per Share---0.084-0.060-28%0.076-211%0.057-247%0.054-255%
Usd Book Value--148538000.000163033500.000-9%139793000.000+6%76800864.368+93%72958669.850+104%
Usd Book Value Change Per Share---0.084-0.060-28%0.076-211%0.057-247%0.054-255%
Usd Book Value Per Share--1.0801.185-9%1.016+6%0.558+93%0.530+104%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.098-0.077-21%-0.071-27%-0.083-15%-0.079-19%
Usd Free Cash Flow---12363000.000-10162000.000-18%-8632750.000-30%-7149498.000-42%-6792417.800-45%
Usd Free Cash Flow Per Share---0.090-0.074-18%-0.063-30%-0.052-42%-0.049-45%
Usd Free Cash Flow To Equity Per Share---0.091-0.069-25%0.075-221%0.042-316%0.040-328%
Usd Market Cap209135267.840-3%214638827.520343284535.040-37%389720819.840-45%236363405.204-9%224545234.944-4%
Usd Price Per Share1.520-3%1.5602.495-37%2.833-45%1.718-9%1.632-4%
Usd Profit---13415000.000-10155000.000-24%-9198750.000-31%-11214210.526-16%-10653923.700-21%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.084-0.060-28%0.076-211%0.057-247%0.054-255%
 EOD+3 -5MRQTTM+6 -23YOY+9 -205Y+12 -1710Y+12 -17

4.2. Fundamental Score

Let's check the fundamental score of Compass Therapeutics Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.897
Price to Book Ratio (EOD)Between0-11.408
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than116.438
Current Ratio (MRQ)Greater than119.726
Debt to Asset Ratio (MRQ)Less than10.053
Debt to Equity Ratio (MRQ)Less than10.056
Return on Equity (MRQ)Greater than0.15-0.090
Return on Assets (MRQ)Greater than0.05-0.086
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Compass Therapeutics Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.490
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets156,875
Total Liabilities8,337
Total Stockholder Equity148,538
 As reported
Total Liabilities 8,337
Total Stockholder Equity+ 148,538
Total Assets = 156,875

Assets

Total Assets156,875
Total Current Assets153,881
Long-term Assets2,994
Total Current Assets
Cash And Cash Equivalents 24,228
Short-term Investments 128,233
Other Current Assets 1,420
Total Current Assets  (as reported)153,881
Total Current Assets  (calculated)153,881
+/-0
Long-term Assets
Property Plant Equipment 2,674
Long-term Assets Other 320
Long-term Assets  (as reported)2,994
Long-term Assets  (calculated)2,994
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,801
Long-term Liabilities536
Total Stockholder Equity148,538
Total Current Liabilities
Accounts payable 4,090
Total Current Liabilities  (as reported)7,801
Total Current Liabilities  (calculated)4,090
+/- 3,711
Long-term Liabilities
Long-term Liabilities  (as reported)536
Long-term Liabilities  (calculated)0
+/- 536
Total Stockholder Equity
Total Stockholder Equity (as reported)148,538
Total Stockholder Equity (calculated)0
+/- 148,538
Other
Capital Stock13
Common Stock Shares Outstanding 127,668
Net Invested Capital 148,538
Net Working Capital 146,080
Property Plant and Equipment Gross 8,941



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302018-12-312018-09-302018-06-30
> Total Assets 
7
2
5
5
1
30,381
4
70,449
60,690
51,911
48,198
40,872
34,899
153,757
146,564
140,256
127,838
199,645
187,975
179,181
170,038
156,875
156,875170,038179,181187,975199,645127,838140,256146,564153,75734,89940,87248,19851,91160,69070,449430,38115527
   > Total Current Assets 
7
2
5
5
1
26,238
4
67,288
57,832
50,202
41,647
34,534
28,572
147,105
140,283
134,545
122,554
194,791
183,602
175,272
166,584
153,881
153,881166,584175,272183,602194,791122,554134,545140,283147,10528,57234,53441,64750,20257,83267,288426,23815527
       Cash And Cash Equivalents 
7
2
5
5
1
25,303
4
65,371
55,518
47,076
39,695
31,208
25,509
144,514
136,379
26,238
16,481
34,946
27,027
19,278
30,426
24,228
24,22830,42619,27827,02734,94616,48126,238136,379144,51425,50931,20839,69547,07655,51865,371425,30315527
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
105,780
104,121
151,663
148,143
149,474
133,277
128,233
128,233133,277149,474148,143151,663104,121105,780000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
320
0
320
320
320
0
0
003203203200320000000000000000
       Other Current Assets 
0
0
0
0
0
935
0
1,917
2,314
3,126
1,952
3,326
3,063
2,591
3,904
2,527
1,952
8,182
8,432
6,520
2,881
1,420
1,4202,8816,5208,4328,1821,9522,5273,9042,5913,0633,3261,9523,1262,3141,917093500000
   > Long-term Assets 
0
0
0
0
0
4,143
0
3,161
2,858
1,709
6,551
6,338
6,327
6,652
6,281
5,711
5,284
4,854
4,373
3,909
3,454
2,994
2,9943,4543,9094,3734,8545,2845,7116,2816,6526,3276,3386,5511,7092,8583,16104,14300000
       Property Plant Equipment 
0
0
0
0
0
3,751
0
2,829
2,418
1,126
6,080
5,808
5,797
6,332
5,961
5,391
4,964
4,534
4,053
3,589
3,134
2,674
2,6743,1343,5894,0534,5344,9645,3915,9616,3325,7975,8086,0801,1262,4182,82903,75100000
       Other Assets 
0
0
0
0
0
0
0
332
440
583
471
530
530
320
320
320
0
320
0
0
0
0
000032003203203205305304715834403320000000
> Total Liabilities 
50
54
66
87
91
148,984
112
17,199
13,403
11,966
14,727
11,997
11,011
13,679
12,074
13,328
11,722
18,007
12,710
10,895
9,993
8,337
8,3379,99310,89512,71018,00711,72213,32812,07413,67911,01111,99714,72711,96613,40317,199112148,9849187665450
   > Total Current Liabilities 
50
54
66
87
91
9,821
112
11,609
9,673
10,099
10,850
8,393
7,683
10,631
9,334
10,884
9,578
16,169
11,190
9,698
9,124
7,801
7,8019,1249,69811,19016,1699,57810,8849,33410,6317,6838,39310,85010,0999,67311,6091129,8219187665450
       Short-term Debt 
0
0
0
0
0
5,576
0
7,454
7,461
7,467
8,499
6,660
4,817
989
1,027
1,051
1,075
1,097
1,122
1,147
1,174
0
01,1741,1471,1221,0971,0751,0511,0279894,8176,6608,4997,4677,4617,45405,57600000
       Short Long Term Debt 
0
0
0
0
0
0
0
7,454
7,461
7,467
7,474
5,611
3,744
0
0
0
0
0
0
0
0
0
0000000003,7445,6117,4747,4677,4617,4540000000
       Accounts payable 
0
0
0
0
0
629
0
1,581
854
1,061
1,061
559
868
867
257
6,532
2,761
3,382
1,125
724
2,306
4,090
4,0902,3067241,1253,3822,7616,5322578678685591,0611,0618541,581062900000
       Other Current Liabilities 
50
54
66
87
91
494
112
2,574
1,358
1,571
1,290
1,174
5,742
8,775
8,050
3,301
5,742
11,690
8,943
7,827
5,644
0
05,6447,8278,94311,6905,7423,3018,0508,7755,7421,1741,2901,5711,3582,5741124949187665450
   > Long-term Liabilities 
0
0
0
0
0
139,163
0
5,590
3,730
1,867
3,877
3,604
3,328
3,048
2,740
2,444
2,144
1,838
1,520
1,197
869
536
5368691,1971,5201,8382,1442,4442,7403,0483,3283,6043,8771,8673,7305,5900139,16300000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
1,867
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001,867000000000
> Total Stockholder Equity
-43
-52
-62
-82
-90
-118,603
-108
53,250
47,287
39,945
33,471
28,875
23,888
140,078
134,490
126,928
116,116
181,638
175,265
168,286
160,045
148,538
148,538160,045168,286175,265181,638116,116126,928134,490140,07823,88828,87533,47139,94547,28753,250-108-118,603-90-82-62-52-43
   Common Stock
1
1
1
1
1
3,305
1
5
5
5
5
6
6
10
10
10
10
13
13
13
13
0
0131313131010101066555513,30511111
   Retained Earnings -315,308-301,893-291,929-280,651-272,814-261,220-249,245-240,751-233,589-220,608-214,634-158,830-151,408-143,017-133,8670-121,908-91-83-62-52-44
   Capital Surplus 
0
0
0
0
0
0
0
0
0
191,348
192,296
243,503
244,490
373,657
375,231
376,675
377,967
454,741
456,049
460,709
0
0
00460,709456,049454,741377,967376,675375,231373,657244,490243,503192,296191,348000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
5,903
-109
193,750
197,358
197,283
196,947
243,503
244,490
373,657
375,231
376,675
377,967
454,741
456,049
460,709
462,355
0
0462,355460,709456,049454,741377,967376,675375,231373,657244,490243,503196,947197,283197,358193,750-1095,90300000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-50,363
Operating Income-50,363-50,363
 
Operating Expense (+$)
Research Development38,120
Selling General Administrative12,243
Selling And Marketing Expenses0
Operating Expense50,36350,363
 
Net Interest Income (+$)
Interest Income7,869
Interest Expense-0
Other Finance Cost-0
Net Interest Income7,869
 
Pretax Income (+$)
Operating Income-50,363
Net Interest Income7,869
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-42,494-50,363
EBIT - interestExpense = 0
-42,494
-42,494
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-42,494
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-42,494
Tax Provision-0
Net Income From Continuing Ops-42,494-42,494
Net Income-42,494
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-7,869
 

Technical Analysis of Compass Therapeutics Inc.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Compass Therapeutics Inc.. The general trend of Compass Therapeutics Inc. is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Compass Therapeutics Inc.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Compass Therapeutics Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.305 < 2.34 < 2.5726.

The bearish price targets are: 1.15.

Tweet this
Compass Therapeutics Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Compass Therapeutics Inc.. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Compass Therapeutics Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Compass Therapeutics Inc..

Compass Therapeutics Inc. Daily Moving Average Convergence/Divergence (MACD) ChartCompass Therapeutics Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Compass Therapeutics Inc.. The current adx is .

Compass Therapeutics Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Compass Therapeutics Inc..

Compass Therapeutics Inc. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Compass Therapeutics Inc..

Compass Therapeutics Inc. Daily Relative Strength Index (RSI) ChartCompass Therapeutics Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Compass Therapeutics Inc..

Compass Therapeutics Inc. Daily Stochastic Oscillator ChartCompass Therapeutics Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Compass Therapeutics Inc..

Compass Therapeutics Inc. Daily Commodity Channel Index (CCI) ChartCompass Therapeutics Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Compass Therapeutics Inc..

Compass Therapeutics Inc. Daily Chande Momentum Oscillator (CMO) ChartCompass Therapeutics Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Compass Therapeutics Inc..

Compass Therapeutics Inc. Daily Williams %R ChartCompass Therapeutics Inc. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Compass Therapeutics Inc..

Compass Therapeutics Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Compass Therapeutics Inc..

Compass Therapeutics Inc. Daily Average True Range (ATR) ChartCompass Therapeutics Inc. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Compass Therapeutics Inc..

Compass Therapeutics Inc. Daily On-Balance Volume (OBV) ChartCompass Therapeutics Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Compass Therapeutics Inc..

Compass Therapeutics Inc. Daily Money Flow Index (MFI) ChartCompass Therapeutics Inc. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Compass Therapeutics Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-13ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Compass Therapeutics Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Compass Therapeutics Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.490
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Compass Therapeutics Inc. with someone you think should read this too:
  • Are you bullish or bearish on Compass Therapeutics Inc.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Compass Therapeutics Inc.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Compass Therapeutics Inc.

I send you an email if I find something interesting about Compass Therapeutics Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Compass Therapeutics Inc..

Receive notifications about Compass Therapeutics Inc. in your mailbox!